Legacy MyConnexus will be retiring on July 1, 2021 and submissions made after that date within MyConnexus will no longer be accepted.
Therefore, we are encouraging all of our clients to take a complimentary training of the new WCG IRB Connexus™ portal to get familiar with navigating the system and the features and benefits you’re sure to enjoy.
To register for a complimentary training session led by our experts, please choose the date and time that works best for you and reserve your seat. Note that each of the training sessions will be recorded if you are unable to attend a live event.
|May 18||9:30 – 10:45am ET||Reserve Your Seat|
|May 27||2:00 – 3:15pm ET||Reserve Your Seat|
|June 1||9:30 – 10:45am ET||Reserve Your Seat|
|June 10||2:00 – 3:15pm ET||Reserve Your Seat|
|June 15||9:30 – 10:45am ET||Reserve Your Seat|
|June 24||2:00 – 3:15pm ET||Reserve Your Seat|
|June 29||9:30 – 10:45am ET||Reserve Your Seat|
About WCG IRB Connexus
The new WCG IRB Connexus supports our commitment to continuously improving the quality of submissions by raising the bar on transparency and compliance through a structured workflow platform.
With state-of-the-art technology, we enable our clients to improve their IRB submission process, eliminate and reduce errors, and achieve the highest ethical standards in the board review process.
In building this new portal, we took cues from the systems we all use in our daily lives that are intuitive and simple. Clients are telling us they can’t imagine ever using another IRB submission portal again now that they see how intuitive it is to use the new WCG IRB Connexus. We’re one incredible team that now operates on a single platform that’s, quite simply, going to change the industry.
Your exemplary online portal is very well organized, easy to navigate and utilize. It saves me so much time in my day. I appreciate that you provide the plethora of resources that you do; other submission portals don’t. Your Connexus system is so good that it’s basically the gold standard for IRB portals as far as I’m concerned.– REGULATORY STUDY MANAGER, ACADEMIC MEDICAL CENTER